Sindhu Cherian

University of Washington — United States

Medicine · Health Sciences

26h-index8.3kcitations106works2.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(30), Lymphoma Diagnosis and Treatment(29), Chronic Lymphocytic Leukemia Research(22), Acute Lymphoblastic Leukemia research(21), Acute Myeloid Leukemia Research(20)

Publications106 total

MRD assessment by flow cytometry in B-ALL made easier
Blood Advances·2025Open Access
Type and degree/number of immunophenotypic abnormalities refine multiparameter flow cytometry (MFC)-based measurable residual disease (MRD) testing in adults allografted for Acute Myeloid Leukemia (AML) in morphologic remission
Blood·2025
Impact of immunophenotype on clinical disease characteristics and outcomes in T‐cell prolymphocytic leukaemia
British Journal of Haematology·2025
Flow Cytometry in Acute Myeloid Leukemia (AML): A Critical Tool for Accurate Diagnosis, Classification, and Monitoring
Clinical Chemistry·2025
Acute Undifferentiated Leukemia and Mixed-Phenotype Acute Leukemias
Elsevier eBooks·2025
Daratumumab and isatuximab differentially affect <scp>CD38</scp> detection on plasma cells in myeloma: Anti‐<scp>CD38</scp> nanobody (clone <scp>JK36</scp>) and <scp>CD319</scp> combination improve flow cytometric identification of plasma cells after targeted therapies
British Journal of Haematology·2025· 1 citedOpen Access
CD4 antigen loss in bronchoalveolar lavage fluid with neutrophilia and infectious organisms: A diagnostic pitfall when analyzing T-cell subsets by flow cytometry
American Journal of Clinical Pathology·2025
1305 T-Cell Populations in Refractory Celiac Disease
Laboratory Investigation·2025Open Access
Extended Follow-up of Dose-Adjusted EPOCH (DA-EPOCH) Plus Inotuzumab Ozogamicin (InO) in Adults with Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL): A Safe and Effective Salvage Therapy
Blood·2024· 1 cited
Impact of Immunophenotype on Clinical Disease Characteristics and Outcomes in T-Cell Prolymphocytic Leukemia
Blood·2024
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL
JAMA Oncology·2024· 10 cited
Genetics and pathologic landscape of lineage switch of acute leukemia during therapy
Blood Cancer Journal·2024· 19 citedOpen Access
Genetics and Pathologic Landscape of Lineage Switch of Acute Leukemia during Therapy: A Multi-institutional Study
2023Open Access
PCNEO, a New Proficiency Testing Program for Flow Cytometric Analysis of Plasma Cell Neoplasms From the College of American Pathologists Diagnostic Immunology and Flow Cytometry Committee
Archives of Pathology & Laboratory Medicine·2023· 2 citedOpen Access
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms
Clinics in Laboratory Medicine·2023· 3 cited
Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia
Haematologica·2023· 6 citedOpen Access
A phase I trial of dose-adjusted EPOCH plus inotuzumab ozogamicin (InO) in adults with relapsed/refractory (R/R) B lymphoblastic leukemia/lymphoma (B-ALL).
Journal of Clinical Oncology·2023· 1 cited
Flow cytometric assessment for minimal/measurable residual disease in B lymphoblastic leukemia/lymphoma in the era of immunotherapy
Cytometry Part B Clinical Cytometry·2023· 16 citedOpen Access
Mature B‐ and plasma‐cell flow cytometric analysis: A review of the impact of targeted therapy
Cytometry Part B Clinical Cytometry·2022· 11 cited
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia
Cancer·2021· 13 cited
page 1 of 6Next →

Frequent Co-authors

Cameron J. Turtle(15), Xueyan Chen(15), David G. Maloney(15), Brent L. Wood(13), Stanley R. Riddell(13), Kevin A. Hay(9), Shelly Heimfeld(7), Laïla‐Aïcha Hanafi(7), Jonathan R. Fromm(7), Carolina Berger(6), Colette Chaney(6), Lorinda Soma(6), Ryan D. Cassaday(6), Daniel Sommermeyer(5), Barbara Pender(5), Daniel Li(5), Michael C. Jensen(5), Brian G. Till(5), Katherine M. Melville(4), Tanya M Budiarto(4)